Jubilant Ingrevia has raised Rs 48 crore through Commercial Papers (‘CPs’) on December 27, 2024. Maturity of the said Commercial Papers will be on February 25, 2025. Tenure of the instrument is 60 days.
The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 148 crore.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| BASF India | 3720.50 |
| Tata Chemicals | 707.90 |
| SRF | 2491.80 |
| Pidilite Inds. | 1403.00 |
| Deepak Nitrite | 1701.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: